[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352945-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352945-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","c5orf46-a-promising-prognosis-risk-indicator-with-implication-in-the-remodeling-of-kircand-pan-cancer-tumor-microenvironments","C5orf46 - a promising prognosis risk indicator with implication in the remodeling of KIRCand pan-cancer tumor microenvironments","","C5orf46 is a recently identified tumor-progression-related gene with still unclear roles across cancers, prompting investigation of its function in human pan-cancer, particularly kidney renal clear cell carcinoma (KIRC). The study integrates physicochemical analysis, expression and alteration profiling, post-transcriptional modulation, and survival analyses. Correlations with tumor microenvironment features, DNA methylation effects, immune infiltration, angiogenesis, ECM degradation, EMT, cancer stemness, and drug sensitivity support C5orf46 as a potential prognostic risk indicator and oncogenic contributor.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/c5orf46-a-promising-prognosis-risk-indicator-with-implication-in-the-remodeling-of-kircand-pan-cancer-tumor-microenvironments/352945/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/c5orf46-a-promising-prognosis-risk-indicator-with-implication-in-the-remodeling-of-kircand-pan-cancer-tumor-microenvironments/352945.png","ImageObject",300,407,{"name":42,"@type":43},"Đào","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study of C5orf46 address in pan-cancer and KIRC?","Question",{"text":63,"@type":64},"It explores how the C5orf46 gene functions in human pan-cancer with emphasis on its potential role in regulating the tumor microenvironment in KIRC, including implications for clinical application.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was C5orf46 evaluated in the study?",{"text":68,"@type":64},"The work combines physicochemical characterization, gene expression and alteration pattern analysis across cancers, post-transcription modulation, survival analysis, and sequential correlation of C5orf46 with multiple TME-related parameters.",{"name":70,"@type":61,"acceptedAnswer":71},"What clinical relevance did the study find for C5orf46 in KIRC patients?",{"text":72,"@type":64},"Upregulated C5orf46 expression in cancers, with the greatest difference in KIRC, correlated with worse overall survival and shorter recurrence-free survival, consistent with an adverse prognosis risk indicator role.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352945,1790823104,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Original Research PUBLISHED 04 May 2026  \nDOI 10.3389/fonc.2026.1713635  \nOPEN ACCESS  \nEDITED BY  \nRavi Mehrotra,  \nEmory University, United States  \nREVIEWED BY  \nDwijendra K. Gupta, Allahabad University, India Wenhua Zhi,  \nPeople’s Hospital of Zhengzhou University, China  \n*CORRESPONDENCE  \nWenxia Ma  \n [mawenxia@sxmu.edu.cn](mawenxia@sxmu.edu.cn)[ ](mawenxia@sxmu.edu.cn)Chen Wang  \n[wangchen@sxmu.edu.cn](wangchen@sxmu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 26 September 2025  \nREVISED 07 April 2026  \nACCEPTED 15 April 2026  \nPUBLISHED 04 May 2026  \nCITATION  \nMiao L, Wang F, Wang X, Yang H, Li J, Liu S, Shen N, Yang Z, Gao L, Ma W and Wang C (2026) C5orf46: a promising prognosis risk indicator with implication in the remodeling of KIRC and pancancer tumor microenvironments. Front. Oncol. 16:1713635 .  \ndoi: 10.3389/fonc.2026.1713635  \nCOPYRIGHT  \n© 2026 Miao, Wang, Wang, Yang, Li, Liu, Shen, Yang, Gao, Ma and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nC5orf46: a promising prognosis risk indicator with implication in the remodeling of KIRCand pan-cancer tumor microenvironments  \nLei Miao 1†, Fei Wang 2,3†, Xuzhi Wang 2, Huijun Yang 2, Jiayao Li 2, Siying Liu 2,3, Ningning Shen 4, Zhiqing Yang 4, Lifang Gao 4, Wenxia Ma 4* and Chen Wang 4*  \n1 Basical College of ShanXi Medical University, Taiyuan, Shanxi, China, 2Second Clinical Medical College of ShanXi Medical University, Taiyuan, Shanxi, China, 3 Public Health School of ShanXi Medical University, Taiyuan, Shanxi, China, 4 Department of Pathology, Second Hospital of ShanXi Medical University, Taiyuan, Shanxi, China  \nIntroduction: C5orf46 is a recently discovered tumor-progression-related gene whose function in most cancers is still unknown, especially its potential role in regulating the tumor microenvironment (TME) . The aim of the study is to explore the function of the C5orf46 gene in human pan-cancer, including kidney renal clear cell carcinoma (KIRC), for potential clinical application.  \nMethods: The study started with the physicochemical properties of C5orf46, then the gene expression as well as alteration patterns in diverse cancers, followed by its post-transcription modulation, and then survival analysis. Moreover, the correlations between C5orf46 and multiple cancer TME-related parameters, including angiogenesis, extracellular matrix (ECM) degradation, and immune inﬁltration, were explored sequentially. Furthermore, C5orf46 ’s association with other critical cancer features, for instance, cancer stemness, tumor epithelial– mesenchymal transition (EMT), and DNA repair, was also investigated.  \nResults: Firstly, the physicochemical properties, including amino acid composition, estimated molecular weight, and protein half-life, of the C5orf46 gene were computed sequentially. Then, based on gene expression as well as survival analysis results, C5orf46 was shown to be upregulated in various human cancers, wherein KIRC showed the greatest difference in C5orf46 expression between cancer and corresponding normal tissues. The change in expression was partly due to DNA methylation modulation. Meanwhile, of greater clinical signiﬁcance, the upregulated C5orf46 expression was correlated with both worse patients ’ overall survival and shorter recurrence-free survival. Moreover, the association between C5orf46 and multiple critical cancer traits, including microenvironment angiogenesis, immune inﬁltration, ECM degradation, and cancer EMT, was validated. Furthermore, the C5orf46 gene was indicated to correlate with the sensitivit","cbCaipPFfd78bCF2","https://ap.wps.com/l/cbCaipPFfd78bCF2","pdf",27199002,23,"English","# Introduction\n## Cancer and tumor microenvironment (TME)\n# Methods\n## Physicochemical properties and expression analyses\n## Survival analysis and TME correlation\n# Results\n## Upregulation and survival impact in cancers including KIRC\n## Links to methylation, TME traits, EMT and drug sensitivity\n# Conclusions","[{\"question\":\"What question does the study of C5orf46 address in pan-cancer and KIRC?\",\"answer\":\"It explores how the C5orf46 gene functions in human pan-cancer with emphasis on its potential role in regulating the tumor microenvironment in KIRC, including implications for clinical application.\"},{\"question\":\"How was C5orf46 evaluated in the study?\",\"answer\":\"The work combines physicochemical characterization, gene expression and alteration pattern analysis across cancers, post-transcription modulation, survival analysis, and sequential correlation of C5orf46 with multiple TME-related parameters.\"},{\"question\":\"What clinical relevance did the study find for C5orf46 in KIRC patients?\",\"answer\":\"Upregulated C5orf46 expression in cancers, with the greatest difference in KIRC, correlated with worse overall survival and shorter recurrence-free survival, consistent with an adverse prognosis risk indicator role.\"}]","C5orf46 - a promising prognosis risk indicator with implication in the remodeling of KIRCand pan-cancer tumor microenvironments | PDF",1790102224,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d981c84272b7444c647301b57a5804d5.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5776a799c7a0fe598491b82d06a898b5.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ccf7e886a05ad58affd6ca6db93b11e.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53a16760a010229bc42bf78d5c3b97ea.webp",980,1385]